Vaccines Market Research Reports & Industry Analysis
Because of the large number of deadly diseases that have been eliminated through the proliferation of effective vaccines, vaccination is generally viewed as one of the greatest public health achievements of the 20th century. Key issues in the global vaccine market today include unequal access to vaccines, supply chain disruptions, the use of vaccines to prevent pandemics and address bioterrorism, technological innovations, and vaccine hesitancy. Learn more about this critical field with the comprehensive selection of vaccine market research reports available on MarketResearch.com.
New Vaccines Market Data and Insights
- Find data on vaccine market size segmented by region, technology, distribution channel, type, route of administration, and disease.
- Gain a deep understanding of vaccine industry dynamics, market structure, growth outlook, and competitive landscape.
- Learn about influential government initiatives and new vaccination technologies that have highly promising results.
Your Source for Expert Data and Analysis
MarketResearch.com is a trusted research partner, backed by over two decades of experience. Our clients include top investment banks, management consulting firms, and leading multinational companies within the Fortune 500. Our team of research specialists is dedicated to guiding you at every step, ensuring you have the resources and insights you need to answer your toughest research questions. Browse our full list of vaccines industry reports today.
Vaccines Industry Research & Market Reports
-
Global Vaccine Refrigerator Market - 2022-2029
... Vaccines are extremely temperature-sensitive, and their deterioration can result from variations in the storage temperature. Commercial refrigerators face the problem of temperature variations that can jeopardize vaccines. Vaccine coolers have stable, ultra-low temperatures specially designed ... Read More
-
Global Veterinary Vaccines Market - 2024 - 2031
... veterinary vaccine is a biological preparation that provides immunity against a particular animal disease. Vaccination plays a crucial role in improving animal health, reducing the spread of zoonotic diseases, and increasing the production of milk, ... Read More
-
Global Toxoid Vaccine Market - 2022-2029
... caused by toxins secreted by specific bacteria. Compared to other vaccines, toxoid vaccines are more stable and less susceptible to damage caused by temperature, humidity, or light. A course of toxoid vaccines induces long-lasting immunity ... Read More
-
Global Live Attenuated Vaccines Market - 2022-2029
... contains the virulence organism that is weakened. These vaccines produce immune response in the body by remaining inactive. These vaccines boost the body to produce antiboidies and memory cells in response to the specific pathogen ... Read More
-
Global Hepatitis A Vaccine Market - 2022-2029
... hepatitis A is on the rise. Asia-Pacific held a dominant position in the global Hepatitis A Vaccine market in 2021. The competitive rivalry intensifies with GlaxoSmithKline, Zhejiang Pukang, KM Biologics and others operating in the ... Read More
-
Global Isothermal Boxes for Vaccine Market - 2023-2030
... Isothermal boxes are the superset of cold boxes and vaccination carriers. Immunization transporters offer similar properties as cold boxes, except they have a smaller volume. Based on the material, isothermal boxes for the vaccine market ... Read More
-
Global Vaccines Market- 2023-2030
... substances designed to stimulate the body's immune system to recognize and fight specific pathogens, like viruses or bacteria. They typically contain a weakened or inactivated form of the pathogen, or pieces of it (like proteins), ... Read More
-
Preventive Healthcare Technologies and Services Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)
... period (2025-2030). In recent times, countries have faced a huge threat of COVID-19. As per the World Health Organization (WHO), coronavirus disease is an infectious disease, and most people infected with the COVID-19 virus will ... Read More
-
H1N1 Vaccines Market Report by Vaccine Type (Intramuscular, Intranasal, Intradermal), Market Type (Public, Private), and Region 2025-2033
... The increasing healthcare concerns, significant medical advancements, improving healthcare systems, and rising awareness about the importance of H1N1 vaccines are some of the major factors propelling the market. H1N1 vaccines, also known as influenza A ... Read More
-
Pharmaceutical Contract Packaging Market Report by Industry (Small Molecule, Biopharmaceutical, Vaccine), Type (Sterile, Non-sterile), Packaging (Plastic Bottles, Caps and Closures, Blister Packs, Prefilled Syringes, Parenteral Vials and Ampoules, and Others), and Region 2025-2033
... 2025-2033. The increasing outsourcing trends, rising demand for medications and medical devices, stringent regulatory compliance, product diversification and cost-effectiveness, significant technological advancements, and increasing environmental considerations are some of the major factors propelling the market. ... Read More
-
mRNA Platform
... CAGR of -2.7% over the analysis period 2024-2030. Covid-19 Vaccine Indication, one of the segments analyzed in the report, is expected to record a -6.3% CAGR and reach US$102.1 Billion by the end of the ... Read More
-
Dengue Vaccine
... CAGR of 15.9% over the analysis period 2024-2030. Government Institutions End-Use, one of the segments analyzed in the report, is expected to record a 14.3% CAGR and reach US$774.6 Million by the end of the ... Read More
-
Meningococcal Vaccines
... CAGR of 4.8% over the analysis period 2024-2030. Quadrivalent Vaccines, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$3.1 Billion by the end of the analysis ... Read More
-
Porcine Vaccines
... CAGR of 4.9% over the analysis period 2024-2030. Inactivated Vaccines Technology, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$1.2 Billion by the end of the ... Read More
-
Vaccine Adjuvants
... CAGR of 9.1% over the analysis period 2024-2030. Particulate Adjuvants, one of the segments analyzed in the report, is expected to record a 8.6% CAGR and reach US$562.7 Million by the end of the analysis ... Read More
-
Shingles Vaccines
... CAGR of 4.9% over the analysis period 2024-2030. Recombinant Vaccines, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$3.9 Billion by the end of the analysis ... Read More
-
Therapeutic Vaccines
... CAGR of 16.7% over the analysis period 2024-2030. Autoimmune Disease Vaccines, one of the segments analyzed in the report, is expected to record a 17.3% CAGR and reach US$62.8 Billion by the end of the ... Read More
-
Foot and Mouth Disease (FMD) Vaccine
... reach US$5.6 Billion by 2030, growing at a CAGR of 9.2% over the analysis period 2024-2030. Conventional Vaccines, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach ... Read More
-
Hepatitis B Vaccines
... at a CAGR of 4.4% over the analysis period 2024-2030. Combination Vaccines, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$2.6 Billion by the end of ... Read More
-
Veterinary Vaccines
... CAGR of 5.6% over the analysis period 2024-2030. Porcine Vaccines, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$4.7 Billion by the end of the analysis ... Read More
-
Human Vaccines
... CAGR of 7.3% over the analysis period 2024-2030. Intramuscular & Subcutaneous Administration, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$58.7 Billion by the end of ... Read More
-
Biodefense
... 4.2% over the analysis period 2024-2030. Anthrax, one of the segments analyzed in the report, is expected to record a 3.2% CAGR and reach US$6.4 Billion by the end of the analysis period. Growth in ... Read More
-
Tetanus Toxoid Vaccine
... at a CAGR of 2.6% over the analysis period 2024-2030. Tetanus, Diphtheria, and Pertussis (Tdap) Vaccine, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$1.7 Billion ... Read More
-
Preventable Vaccines
... CAGR of 1.1% over the analysis period 2024-2030. Live / Attenuated Vaccines, one of the segments analyzed in the report, is expected to record a 1.2% CAGR and reach US$34.1 Billion by the end of ... Read More
-
Cancer Vaccines
... CAGR of 9.3% over the analysis period 2024-2030. Preventive Vaccine, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach US$7.6 Billion by the end of the analysis ... Read More
Research Assistance
